Synthesis and cellular uptake of porphyrin decorated iron oxide nanoparticles - A potential candidate for bimodal anticancer therapy
Chemical Communications, ISSN: 1359-7345, Issue: 34, Page: 4270-4272
2005
- 188Citations
- 117Captures
Metric Options: CountsSelecting the 1-year or 3-year option will change the metrics count to percentiles, illustrating how an article or review compares to other articles or reviews within the selected time period in the same journal. Selecting the 1-year option compares the metrics against other articles/reviews that were also published in the same calendar year. Selecting the 3-year option compares the metrics against other articles/reviews that were also published in the same calendar year plus the two years prior.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Metrics Details
- Citations188
- Citation Indexes187
- 187
- CrossRef159
- Patent Family Citations1
- Patent Families1
- Captures117
- Readers117
- 117
Article Description
This paper reports the synthesis, characterization, and cellular uptake of the conjugate of porphyrin and iron oxide nanoparticles, which may lead to a bimodal anticancer agent that can be used in the combinational treatment of photodynamic therapy (PDT) and hyperthermia therapy (HT). © The Royal Society of Chemistry 2005.
Bibliographic Details
http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=25144458911&origin=inward; http://dx.doi.org/10.1039/b507779f; http://www.ncbi.nlm.nih.gov/pubmed/16113718; https://xlink.rsc.org/?DOI=b507779f; https://dx.doi.org/10.1039/b507779f; https://pubs.rsc.org/en/content/articlelanding/2005/cc/b507779f
Royal Society of Chemistry (RSC)
Provide Feedback
Have ideas for a new metric? Would you like to see something else here?Let us know